IMI European Lead Factory — democratizing access to highthroughput screening

Jones, PS; Waldmann, Herbert

doi:10.1038/d41573-021-00196-3

Lokale TagsFreigabegeschichteDetailsÜbersicht

IMI European Lead Factory — democratizing access to highthroughput screening

Jones, P., & Waldmann, H. (2022). IMI European Lead Factory — democratizing access to highthroughput screening. Nature Reviews Drug Discovery, 21, 245-246. doi:10.1038/d41573-021-00196-3.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/21.11116/0000-000A-D0F6-5 Versions-Permalink: https://hdl.handle.net/21.11116/0000-000A-D0F8-3

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Jones, PS¹, Autor
Waldmann, Herbert², Autor

Affiliations:
1BioAscent Discovery, Glasgow, United Kingdom., ou_persistent22
2Abt. IV: Chemische Biologie, Max Planck Institute of Molecular Physiology, Max Planck Society, ou_1753290